Loading...
Loading...
By Juan Luis Serrano Leets - Thu, 05/29/2025 - 08:00
Mexico cancels 2025-26 drug procurement due to violations by Birmex, raising transparency and supply chain concerns - Juan Luis Serrano Leets.
https://mexicobusiness.news/tag/juan-luis-serrano-leets
More Health
By Juan Luis Serrano Leets - Mon, 03/10/2025 - 06:30
Mexico's patent and biosimilar regulations lack transparency and efficiency. Reform is needed, writes Juan Luis Serrano Leets.
By Juan Luis Serrano Leets - Thu, 12/12/2024 - 16:00
With a newly designated head commissioner, Juan Luis Serrano looks at the key challenges COFEPRIS will likely face in 2025.
By Sofía Garduño - Tue, 07/09/2024 - 07:48
Continued efforts to enhance efficiency in regulatory processes foster a more conducive environment for innovation, says Sánchez Devanny.
By Juan Luis Serrano Leets - Thu, 06/06/2024 - 08:00
COFEPRIS guidelines set an action plan based on regulatory certainty through which companies can invest in the sector, explains Juan Luis Serrano.
By Juan Luis Serrano Leets - Thu, 06/01/2023 - 12:00
Coming decision will impact the future of advertisement and use of IP for pre-packaged food and drink products, writes Juan Luis Serrano Leets.
By Miriam Bello - Mon, 09/05/2022 - 12:24
Advances and ongoing challenges have paved the way for the transformation of Mexico’s health system.
By Sofía Garduño - Wed, 08/31/2022 - 16:32
Healthcare providers are embracing pharmacoeconomics to make better decisions, but the field must also improve.
By Miriam Bello - Wed, 08/10/2022 - 08:28
The Digital Health Law and other regulations need clarity to support the provision of health services, says Sanchez Devanny's Juan Luis Serrano.
By Juan Luis Serrano Leets - Mon, 07/25/2022 - 09:00
Patent owners in Mexico are benefiting from a Supreme Court decision related to prosecution delays and compensation, writes Juan Luis Serrano.
